- Home
- BGLC vs AMZE Comparison
BGLC vs AMZE Comparison
Compare BGLC & AMZE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BGLC
- AMZE
- Stock Information
- Founded
- BGLC 2017
- AMZE 2019
- Country
- BGLC Malaysia
- AMZE United States
- Employees
- BGLC N/A
- AMZE N/A
- Industry
- BGLC Medical Specialities
- AMZE Beverages (Production/Distribution)
- Sector
- BGLC Health Care
- AMZE Consumer Staples
- Exchange
- BGLC Nasdaq
- AMZE Nasdaq
- Market Cap
- BGLC 5.0M
- AMZE 5.2M
- IPO Year
- BGLC N/A
- AMZE 2021
- Fundamental
- Price
- BGLC $6.41
- AMZE $9.06
- Analyst Decision
- BGLC
- AMZE
- Analyst Count
- BGLC 0
- AMZE 0
- Target Price
- BGLC N/A
- AMZE N/A
- AVG Volume (30 Days)
- BGLC 2.7M
- AMZE 83.5K
- Earning Date
- BGLC 08-13-2025
- AMZE 08-13-2025
- Dividend Yield
- BGLC N/A
- AMZE N/A
- EPS Growth
- BGLC N/A
- AMZE N/A
- EPS
- BGLC N/A
- AMZE N/A
- Revenue
- BGLC $9,265,870.00
- AMZE $254,711.00
- Revenue This Year
- BGLC N/A
- AMZE N/A
- Revenue Next Year
- BGLC N/A
- AMZE N/A
- P/E Ratio
- BGLC N/A
- AMZE N/A
- Revenue Growth
- BGLC N/A
- AMZE N/A
- 52 Week Low
- BGLC $2.01
- AMZE $5.78
- 52 Week High
- BGLC $15.60
- AMZE $28.72
- Technical
- Relative Strength Index (RSI)
- BGLC 60.18
- AMZE N/A
- Support Level
- BGLC $5.56
- AMZE N/A
- Resistance Level
- BGLC $15.60
- AMZE N/A
- Average True Range (ATR)
- BGLC 0.96
- AMZE 0.00
- MACD
- BGLC 0.52
- AMZE 0.00
- Stochastic Oscillator
- BGLC 29.46
- AMZE 0.00
About BGLC BioNexus Gene Lab Corp Common stock
BioNexus Gene Lab Corp, through its wholly owned subsidiary, focuses on the sale of chemical raw materials for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electronic industries in the Southeast Asia region. These countries include Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. In addition, the Company is in the business of developing and providing safe, effective, and non-invasive liquid biopsy tests for the early detection of biomarkers that it believes are linked to diseases to minimize treatment costs and improve patient management. Its non-invasive blood tests provide analysis of changes in RNA to detect the potential risk of different diseases.
About AMZE Amaze Holdings Inc. Common Stock
Amaze Holdings Inc is engaged in producer of low carb, low calorie, premium wines in the United States. The company offers bold, crisp, and creamy wines that embody health, warmth, and a deeper connection to wellness and an active lifestyle. The company currently sell seven proprietary varietals: Cabernet Sauvignon, Pinot Noir, Chardonnay, Sauvignon Blanc, Rose, Sparkling Rose, and a limited Reserve Napa Cabernet Sauvignon.